IL-2

Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
Joseph I. Clark, Shams Bufalino, Shruti Singh, Ewa Borys

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 53; DOI: 10.1186/s40425-018-0370-6
Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation
Hua Jing, Michael Hettich, Simone Gaedicke, Elke Firat, Mark Bartholomä, Gabriele Niedermann

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 55; DOI: 10.1186/s40425-019-0537-9
Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8⁺ T cells
Michael J McNamara, Melissa J Kasiewicz, Stefanie N Linch, Christopher Dubay, William L Redmond

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 28; DOI: 10.1186/s40425-014-0028-y
IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy
Zhenjiang Liu, Qingda Meng, Markus Maeurer, Elena Rangelova, Thomas Poiret, Rebecca Robertson, Aditya Ambati, Lalit Rane, Jiri Bartek, Caroline Verbeke, Oscar Persson, Matthias Löhr, Ralf Segersvärd, Ernest Dodoo

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P31; DOI: 10.1186/2051-1426-3-S2-P31
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
Mohanad H. Nada, Hong Wang, Grefachew Workalemahu, Yoshimasa Tanaka, Craig T. Morita

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 9; DOI: 10.1186/s40425-017-0209-6
Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen
Gilda G. Hillman, Lyndsey A. Reich, Shoshana E. Rothstein, Lisa M. Abernathy, Matthew D. Fountain, Kali Hankerd, Christopher K. Yunker, Joseph T. Rakowski, Eric Quemeneur, Philippe Slos

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 4; DOI: 10.1186/s40425-016-0204-3

Log in using your username and password

Main menu

Log in using your username and password

You are here

IL-2